ESOPREVEG IT

ESOPREVEG IT Capsules combine Esomeprazole 40 mg, a proton pump inhibitor (PPI), with Itopride Hydrochloride 150 mg (Sustained Release), a prokinetic agent, to provide effective relief from acid reflux, gastroesophageal reflux disease (GERD), acidity, gastritis, and functional dyspepsia. This dual-action formulation reduces excess stomach acid production while enhancing gastrointestinal motility, helping relieve symptoms such as heartburn, bloating, nausea, early fullness, and indigestion.

ESOPREVEG IT Capsules are designed to improve digestive health by addressing both acid secretion and delayed gastric emptying, offering long-lasting relief from acid-related gastrointestinal disorders.

Key Benefits

• Effectively relieves acidity and heartburn
• Helps manage GERD (Gastroesophageal Reflux Disease)
• Reduces excess stomach acid production
• Improves gastric emptying and digestive motility
• Relieves bloating, nausea, and indigestion
• Promotes long-lasting digestive comfort and gut health